SCNI · Scinai Immunotherapeutics Ltd ADR
United States · RS rating 34 · As of 2026-11-03
| Price | 0.47 USD |
|---|---|
| 1-day change | -0.4% |
| RS rating (overall / 1M / 3M / 12M) | 34 / 3 / 97 / 14 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 31 / 31 / 35 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +22.6% |
| Distance from 52-week high | +85.3% |
| Market cap (USD) | $1.6M |